Recurrence Score-guiding Chemotherapy in Non-pCR HR Positive HER2 Negative Breast Cancer After Neoadjuvant Therapy
Clinical trial NCT03638648 · UNKNOWN
Trial details
- NCT number
- NCT03638648
- Sponsor
- Zhejiang Cancer Hospital
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-11-01
- Primary completion
- 2020-12-30
- Enrollment
- 80
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.